Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia.
Saved in:
| Title: | Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia. |
|---|---|
| Authors: | Parker H; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Rose-Zerilli MJ; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Larrayoz M; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Clifford R; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK., Edelmann J; Department of Internal Medicine III, Ulm University, Ulm, Germany., Blakemore S; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Gibson J; Centre for Biological Sciences, Faculty of Natural and Environmental Sciences, University of Southampton, Southampton, UK., Wang J; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary's, University of London, London, UK., Ljungström V; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Wojdacz TK; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Chaplin T; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary's, University of London, London, UK., Roghanian A; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Davis Z; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK., Parker A; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK., Tausch E; Department of Internal Medicine III, Ulm University, Ulm, Germany., Ntoufa S; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Ramos S; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK., Robbe P; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK., Alsolami R; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK., Steele AJ; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Packham G; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Rodríguez-Vicente AE; Department of Haematology, University Hospital of Salamanca-Biomedical Research Institute of Salamanca, IBMCC, Comprehensive Cancer Center Research, University of Salamanca-CSIC, Salamanca, Spain., Brown L; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., McNicholl F; Department of Haematology, Altnagelvin Area Hospital, Western Health and Social Care Trust, Londonderry, UK., Forconi F; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Pettitt A; Department of Molecular and Clinical Cancer Medicine, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK., Hillmen P; Department of Haematology, St James's University Hospital, Leeds, UK., Dyer M; College of Medicine, Biological Sciences and Psychology, University of Leicester, Leicester, UK., Cragg MS; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK., Chelala C; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary's, University of London, London, UK., Oakes CC; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Rosenquist R; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Stamatopoulos K; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Stilgenbauer S; Department of Internal Medicine III, Ulm University, Ulm, Germany., Knight S; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK., Schuh A; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK., Oscier DG; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK., Strefford JC; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK. |
| Source: | Leukemia [Leukemia] 2016 Nov; Vol. 30 (11), pp. 2179-2186. Date of Electronic Publication: 2016 May 20. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27282254 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Parker+H%22">Parker H</searchLink>; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Rose-Zerilli+MJ%22">Rose-Zerilli MJ</searchLink>; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Larrayoz+M%22">Larrayoz M</searchLink>; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Clifford+R%22">Clifford R</searchLink>; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Edelmann+J%22">Edelmann J</searchLink>; Department of Internal Medicine III, Ulm University, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Blakemore+S%22">Blakemore S</searchLink>; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Gibson+J%22">Gibson J</searchLink>; Centre for Biological Sciences, Faculty of Natural and Environmental Sciences, University of Southampton, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary's, University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Ljungström+V%22">Ljungström V</searchLink>; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Wojdacz+TK%22">Wojdacz TK</searchLink>; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Chaplin+T%22">Chaplin T</searchLink>; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary's, University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Roghanian+A%22">Roghanian A</searchLink>; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Davis+Z%22">Davis Z</searchLink>; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK.<br /><searchLink fieldCode="AU" term="%22Parker+A%22">Parker A</searchLink>; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK.<br /><searchLink fieldCode="AU" term="%22Tausch+E%22">Tausch E</searchLink>; Department of Internal Medicine III, Ulm University, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Ntoufa+S%22">Ntoufa S</searchLink>; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Ramos+S%22">Ramos S</searchLink>; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Robbe+P%22">Robbe P</searchLink>; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Alsolami+R%22">Alsolami R</searchLink>; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Steele+AJ%22">Steele AJ</searchLink>; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Packham+G%22">Packham G</searchLink>; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Rodríguez-Vicente+AE%22">Rodríguez-Vicente AE</searchLink>; Department of Haematology, University Hospital of Salamanca-Biomedical Research Institute of Salamanca, IBMCC, Comprehensive Cancer Center Research, University of Salamanca-CSIC, Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Brown+L%22">Brown L</searchLink>; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22McNicholl+F%22">McNicholl F</searchLink>; Department of Haematology, Altnagelvin Area Hospital, Western Health and Social Care Trust, Londonderry, UK.<br /><searchLink fieldCode="AU" term="%22Forconi+F%22">Forconi F</searchLink>; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Pettitt+A%22">Pettitt A</searchLink>; Department of Molecular and Clinical Cancer Medicine, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.<br /><searchLink fieldCode="AU" term="%22Hillmen+P%22">Hillmen P</searchLink>; Department of Haematology, St James's University Hospital, Leeds, UK.<br /><searchLink fieldCode="AU" term="%22Dyer+M%22">Dyer M</searchLink>; College of Medicine, Biological Sciences and Psychology, University of Leicester, Leicester, UK.<br /><searchLink fieldCode="AU" term="%22Cragg+MS%22">Cragg MS</searchLink>; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.<br /><searchLink fieldCode="AU" term="%22Chelala+C%22">Chelala C</searchLink>; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary's, University of London, London, UK.<br /><searchLink fieldCode="AU" term="%22Oakes+CC%22">Oakes CC</searchLink>; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Rosenquist+R%22">Rosenquist R</searchLink>; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Stamatopoulos+K%22">Stamatopoulos K</searchLink>; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Stilgenbauer+S%22">Stilgenbauer S</searchLink>; Department of Internal Medicine III, Ulm University, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Knight+S%22">Knight S</searchLink>; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Schuh+A%22">Schuh A</searchLink>; Oxford National Institute for Health Research, Biomedical Research Centre/Molecular Diagnostic Centre, University of Oxford, Oxford, UK.<br /><searchLink fieldCode="AU" term="%22Oscier+DG%22">Oscier DG</searchLink>; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.; Department of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK.<br /><searchLink fieldCode="AU" term="%22Strefford+JC%22">Strefford JC</searchLink>; Academic Unit of Cancer Sciences, Faculty of Medicine, Cancer Research UK Centre and Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2016 Nov; Vol. 30 (11), pp. 2179-2186. <i>Date of Electronic Publication: </i>2016 May 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27282254 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/leu.2016.134 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2179 Titles: – TitleFull: Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Parker H – PersonEntity: Name: NameFull: Rose-Zerilli MJ – PersonEntity: Name: NameFull: Larrayoz M – PersonEntity: Name: NameFull: Clifford R – PersonEntity: Name: NameFull: Edelmann J – PersonEntity: Name: NameFull: Blakemore S – PersonEntity: Name: NameFull: Gibson J – PersonEntity: Name: NameFull: Wang J – PersonEntity: Name: NameFull: Ljungström V – PersonEntity: Name: NameFull: Wojdacz TK – PersonEntity: Name: NameFull: Chaplin T – PersonEntity: Name: NameFull: Roghanian A – PersonEntity: Name: NameFull: Davis Z – PersonEntity: Name: NameFull: Parker A – PersonEntity: Name: NameFull: Tausch E – PersonEntity: Name: NameFull: Ntoufa S – PersonEntity: Name: NameFull: Ramos S – PersonEntity: Name: NameFull: Robbe P – PersonEntity: Name: NameFull: Alsolami R – PersonEntity: Name: NameFull: Steele AJ – PersonEntity: Name: NameFull: Packham G – PersonEntity: Name: NameFull: Rodríguez-Vicente AE – PersonEntity: Name: NameFull: Brown L – PersonEntity: Name: NameFull: McNicholl F – PersonEntity: Name: NameFull: Forconi F – PersonEntity: Name: NameFull: Pettitt A – PersonEntity: Name: NameFull: Hillmen P – PersonEntity: Name: NameFull: Dyer M – PersonEntity: Name: NameFull: Cragg MS – PersonEntity: Name: NameFull: Chelala C – PersonEntity: Name: NameFull: Oakes CC – PersonEntity: Name: NameFull: Rosenquist R – PersonEntity: Name: NameFull: Stamatopoulos K – PersonEntity: Name: NameFull: Stilgenbauer S – PersonEntity: Name: NameFull: Knight S – PersonEntity: Name: NameFull: Schuh A – PersonEntity: Name: NameFull: Oscier DG – PersonEntity: Name: NameFull: Strefford JC IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2016 Nov Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1476-5551 Numbering: – Type: volume Value: 30 – Type: issue Value: 11 Titles: – TitleFull: Leukemia Type: main |
| ResultId | 1 |